Abiopharma

EXAGEN INC. (XGN) Announces Executive and Board Changes EXAGEN INC. (XGN) announced changes to its leadership team and board of directors. The position includes: all committee, Audit Committee, Governance Committee, the Committee, McKhannXCC Committee, Nominating and Corporate Governance Committee. The change is effective as of April 17, 2026. Executive Changes Details:

• Personnel Involved: Directors or, Certain Officers
• Committee Assignments: all committee, Audit Committee, Governance Committee, the Committee, McKhannXCC Committee, Nominating and Corporate Governance Committee
• Effective Date: April 17, 2026